159 related articles for article (PubMed ID: 17901905)
1. Reversal of P-glycoprotein-mediated multidrug resistance by cholesterol derived from low density lipoprotein in a vinblastine-resistant human lymphoblastic leukemia cell line.
Shu Y; Liu H
Biochem Cell Biol; 2007 Oct; 85(5):638-46. PubMed ID: 17901905
[TBL] [Abstract][Full Text] [Related]
2. Control of P-glycoprotein activity by membrane cholesterol amounts and their relation to multidrug resistance in human CEM leukemia cells.
Gayet L; Dayan G; Barakat S; Labialle S; Michaud M; Cogne S; Mazane A; Coleman AW; Rigal D; Baggetto LG
Biochemistry; 2005 Mar; 44(11):4499-509. PubMed ID: 15766280
[TBL] [Abstract][Full Text] [Related]
3. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells.
Liu ZL; Hirano T; Tanaka S; Onda K; Oka K
J Pharm Pharmacol; 2003 Nov; 55(11):1531-7. PubMed ID: 14713364
[TBL] [Abstract][Full Text] [Related]
4. Cytogenetic and molecular characterization of tumors in nude mice derived from a multidrug-resistant human leukemia cell line.
Hill AB; Beck WT; Trent JM
Cancer Res; 1988 Jan; 48(2):393-8. PubMed ID: 2891436
[TBL] [Abstract][Full Text] [Related]
5. Selective modulation of P-glycoprotein-mediated drug resistance.
Bebawy M; Morris MB; Roufogalis BD
Br J Cancer; 2001 Dec; 85(12):1998-2003. PubMed ID: 11747345
[TBL] [Abstract][Full Text] [Related]
6. Mode of action of torilin in multidrug-resistant cancer cell lines.
Kim SE; Hong YS; Kim YC; Lee JJ
Planta Med; 1998 May; 64(4):335-8. PubMed ID: 9619116
[TBL] [Abstract][Full Text] [Related]
7. Characterization of 2-chloro-N10-substituted phenoxazines for reversing multidrug resistance in cancer cells.
Thimmaiah KN; Jayashree BS; Germain GS; Houghton PJ; Horton JK
Oncol Res; 1998; 10(1):29-41. PubMed ID: 9613455
[TBL] [Abstract][Full Text] [Related]
8. The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells.
Holland ML; Panetta JA; Hoskins JM; Bebawy M; Roufogalis BD; Allen JD; Arnold JC
Biochem Pharmacol; 2006 Apr; 71(8):1146-54. PubMed ID: 16458258
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of steroidal alkaloids on drug transport and multidrug resistance in human cancer cells.
Lavie Y; Harel-Orbital T; Gaffield W; Liscovitch M
Anticancer Res; 2001; 21(2A):1189-94. PubMed ID: 11396162
[TBL] [Abstract][Full Text] [Related]
10. Energy-dependent reduced drug binding as a mechanism of Vinca alkaloid resistance in human leukemic lymphoblasts.
Beck WT; Cirtain MC; Lefko JL
Mol Pharmacol; 1983 Nov; 24(3):485-92. PubMed ID: 6579344
[TBL] [Abstract][Full Text] [Related]
11. Pervilleine A, a novel tropane alkaloid that reverses the multidrug-resistance phenotype.
Mi Q; Cui B; Silva GL; Lantvit D; Lim E; Chai H; You M; Hollingshead MG; Mayo JG; Kinghorn AD; Pezzuto JM
Cancer Res; 2001 May; 61(10):4030-7. PubMed ID: 11358822
[TBL] [Abstract][Full Text] [Related]
12. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
Wang TX; Yang XH
Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
[TBL] [Abstract][Full Text] [Related]
13. Acridones circumvent P-glycoprotein-associated multidrug resistance (MDR) in cancer cells.
Gopinath VS; Thimmaiah P; Thimmaiah KN
Bioorg Med Chem; 2008 Jan; 16(1):474-87. PubMed ID: 17933543
[TBL] [Abstract][Full Text] [Related]
14. Specific reversal of multidrug resistance to colchicine in CEM/VLB(100) cells by Gynostemma pentaphyllum extract.
Huang TH; Bebawy M; Tran VH; Roufogalis BD
Phytomedicine; 2007 Dec; 14(12):830-9. PubMed ID: 17950589
[TBL] [Abstract][Full Text] [Related]
15. Effect of pO2 on antitumor drug cytotoxicity on MDR and non-MDR variants selected from the LoVo metastatic colon carcinoma cell line.
Lelong-Rebel I; Brisson C; Fabre M; Bergerat JP; Rebel G
Anticancer Res; 2008; 28(1A):55-68. PubMed ID: 18383825
[TBL] [Abstract][Full Text] [Related]
16. Reversal of drug resistance in P-glycoprotein-expressing T-cell acute lymphoblastic CEM leukemia cells by copper N-(2-hydroxy acetophenone) glycinate and oxalyl bis (N-phenyl) hydroxamic acid.
Majumder S; Dutta P; Mukherjee P; Datta ER; Efferth T; Bhattacharya S; Choudhuri SK
Cancer Lett; 2006 Nov; 244(1):16-23. PubMed ID: 16410038
[TBL] [Abstract][Full Text] [Related]
17. Mutational analysis of P-glycoprotein: suppression of caspase activation in the absence of ATP-dependent drug efflux.
Tainton KM; Smyth MJ; Jackson JT; Tanner JE; Cerruti L; Jane SM; Darcy PK; Johnstone RW
Cell Death Differ; 2004 Sep; 11(9):1028-37. PubMed ID: 15131592
[TBL] [Abstract][Full Text] [Related]
18. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
[TBL] [Abstract][Full Text] [Related]
19. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
Li X; Sun B; Zhu CJ; Yuan HQ; Shi YQ; Gao J; Li SJ; Lou HX
Toxicol In Vitro; 2009 Feb; 23(1):29-36. PubMed ID: 18938236
[TBL] [Abstract][Full Text] [Related]
20. Alterations of vinblastine influx in multidrug-resistant lymphoblastic leukaemic CEM cells.
Colin M; Madoulet C; Warren L; Jardillier JC
Anticancer Res; 1996; 16(1):407-12. PubMed ID: 8615645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
